Bio-Techne (BSP:T1CH34) Gross Profit : R$3,792 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Gross Profit?

Bio-Techne's gross profit for the three months ended in Mar. 2024 was R$1,019 Mil. Bio-Techne's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was R$3,792 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Bio-Techne's gross profit for the three months ended in Mar. 2024 was R$1,019 Mil. Bio-Techne's Revenue for the three months ended in Mar. 2024 was R$1,511 Mil. Therefore, Bio-Techne's Gross Margin % for the quarter that ended in Mar. 2024 was 67.43%.

Bio-Techne had a gross margin of 67.43% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Bio-Techne was 70.27%. The lowest was 65.41%. And the median was 67.59%.

Bio-Techne Gross Profit Historical Data

The historical data trend for Bio-Techne's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Gross Profit Chart

Bio-Techne Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Gross Profit

Get a 7-Day Free Trial

1,825.64

2,507.00

3,182.29

3,818.57

3,736.45

Bio-Techne Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross Profit	Get a 7-Day Free Trial															1,052.98	993.54	914.60	865.24	1,018.86

Competitive Comparison of Bio-Techne's Gross Profit

For the Biotechnology subindustry, Bio-Techne's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Techne's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Gross Profit distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Gross Profit falls into.

Bio-Techne Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Bio-Techne's Gross Profit for the fiscal year that ended in Jun. 2023 is calculated as

Gross Profit (A: Jun. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	5517.21	-	1780.759
	=	3,736

Bio-Techne's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )	=	Revenue	-	Cost of Goods Sold
	=	1511.011	-	492.149
	=	1,019

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$3,792 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Bio-Techne's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )	=	Gross Profit (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	1,019	/	1511.011
	=	67.43 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Bio-Techne (BSP:T1CH34) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Bio-Techne had a gross margin of 67.43% for the quarter that ended in Mar. 2024 => Durable competitive advantage

Bio-Techne Gross Profit Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Techne (BSP:T1CH34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

TECH:USA TE1:Germany

Address

614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website

https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne (BSP:T1CH34) Headlines

No Headlines